receptors. This shows that the predominant association of GABA B(1a,2) receptors with glutamatergic terminals is a feature that is preserved at several brain synapses. Furthermore, our data indicate that the cognitive deficits observed with mice lacking GABA B(1a,2) receptors could to some extent relate to attention deficits caused by disinhibited release of glutamate onto TCR neurons.
Introduction
Most sensory inputs are conveyed to the cortex via the thalamus. Thalamocortical relay (TCR) cells constitute the main projection neurons in the thalamus. They receive excitatory inputs from the periphery as well as corticothalamic projections (Sherman and Guillery, 1996) . The latter are thought to be involved in focusing attention onto particular sensory stimuli (Cudeiro and Sillito, 2006) . Feedforward (somatofugal) inhibition onto TCR cells is largely mediated via local interneurons, while feedback (corticofugal) inhibition originates from the thalamic reticular nucleus (TRN) . TRN neurons in turn can be excited by either thalamic or cortical inputs. The relative balance of excitatory and inhibitory influences onto TCR cells largely determines their output, which is thought to be important for signal processing and attention mechanisms.
It is well known that GABA B ( -Amino-Butyric-Acid) receptors regulate the excitability of TCR cells, but it remains unclear which receptor subtypes are associated with pre-and postsynaptic sites (Lee et al., 1994; Crunelli and Leresche, 1991; Gervasi et al. 2003; Ulrich and Huguenard, 1996) . GABA B receptors are heteromeric complexes composed of GABA B1 and GABA B2 subunits (Bettler et al. 2004) . Receptor heterogeneity results from the two subunit isoforms GABA B1a and GABA B1b , both of which combine with GABA B2 to form functional receptors. Presynaptically, GABA B receptors are known to inhibit the release of GABA (autoreceptors) and other neurotransmitters (heteroreceptors). Postsynaptically, GABA B receptors generate a late IPSP via activation of Kir3-type K + channels (Lüscher at al. 1997) . GABA B(1a,2) and GABA B(1b,2) receptors exhibit no pharmacological or functional differences when expressed in heterologous cells. However, studies using mice lacking GABA B1a or GABA B1b subunits, here referred to as 1a -/-and 1b -/-mice, revealed that GABA B receptor subtypes localize to distinct synaptic sites in the amygdala, cortex and hippocampus (Perez-Garci et al. 2006 , Shaban et al. 2006 Vigot et al. 2006, Ulrich and Bettler 2007 ). An emerging feature of GABA B receptor compartmentalization is the predominant association of GABA B(1a,2) receptors with glutamatergic boutons. Similarly, GABA B(1a,2) receptors are present at GABAergic terminals in the neocortex (Perez-Garci et al. 2006), but GABA B(1a,2) as well as GABA B(1b,2) receptors localize to GABAergic terminals in the amygdala and hippocampus (Shaban et al. 2006; Vigot et al. 2006) . Postsynaptic GABA B responses in the hippocampus and neocortex are largely mediated by GABA B(1b,2) receptors, while both receptor subtypes activate postsynaptic Kir3 channels in the amygdala to a similar extent. Consistent with unique in vivo functions for GABA B receptor subtypes, it was shown that 1a -/-and 1b-/-mice exhibit selective deficits in learning and memory tasks (Jacobson et al. 2006; Shaban et al. 2006; Vigot et al. 2006 Currents) and EPSCs (Excitatory Post-Synaptic Currents) were evoked by constant current pulses (0.1 ms, 50 -500 µA) via Platinum/Iridium electrodes (FHC, Bowdoin, ME) with a stimulus isolator (WPI, Sarasota, FL). Current and voltage traces were digitized at 3 kHz with a Digidata 1200A analog-to-digital converter (Molecular Devices, Union City, CA). All drugs were from Tocris (Bristol, UK) and applied via the perfusate. IPSC and EPSC amplitudes were determined by subtracting 3-5 ms time-averaged baseline current segments from the IPSC or EPSC peak current. Data are presented as mean±S.D and (n) designates the number of cells.
Results
To map Gähwiler and Brown 1985) . EPSCs were small and of slow kinetics, reflecting their origin from distal dendrites, which is in line with the known localization of the corticothalamic inputs (Sherman and Guillery 1996) . In WT mice bath application of the GABA B receptor agonist baclofen (25 µM) significantly reduced the EPSC amplitudes from -31±12 pA to -13±9 pA (n=6 cells, p<0.02, paired t-test). This reduction was reversed by application of the GABA B receptor antagonist CGP52432 (1µM, Fig. 1A-C) . The EPSCs were always fully blocked by application of the AMPA ( -Amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid) and NMDA (N-Methyl-D-aspartate) receptor antagonists DNQX (6,7
Dinitroquinoxaline-2,3-dione, 20 µM) and APV (Amino-phosphono-valeric acid, 50 µM), respectively, demonstrating that the EPSCs were purely glutamatergic ( Fig. 1A-C contrast, no significant differences were seen between WT and 1b -/-mice (Fig. 1D ). This shows that GABA B -mediated inhibition of glutamate release at corticothalamic fibers is predominantly mediated by GABA B(1a,2) receptors.
We next investigated presynaptic inhibition of GABA release at axon terminals of TRN neurons. Glutamatergic synaptic transmission was blocked by bath application of the AMPA/NMDA receptor antagonists DNQX/APV and monosynaptic composite inhibitory synaptic currents (IPSCs) were elicited by extracellular stimulation within the ventrobasal complex or the TRN ( Fig. 2A-C 1985) . Bath application of the GABA B receptor agonist baclofen led to a significant reduction of the IPSC amplitudes by ~70 % and this reduction was reversed by the GABA B receptor antagonist CGP52432 ( Fig. 2A-C) . The complete block of IPSCs by bicuculline at the end of the recordings confirmed that the IPSCs were mediated by GABA A receptors ( Fig. 2A-C) . IPSC amplitude reduction by GABA B receptors was not significantly different between WT (73 ± 23%, n=6 cells), 1a -/-(71 ± 15%, n=6) and 1b -/-(71 ± 13%, n=6) mice (Fig. 2D ). This supports that GABA B(1a,2) and GABA B(1b,2) receptors both act as autoreceptors in this inhibitory cell type.
IPSC and EPSC amplitudes after GABA B receptor blockade with CGP52432 were not significantly increased versus control in either genotype, suggesting the absence of tonic or constitutive GABA B receptor activity. Additionally, analysis-of-variance of absolute ISPC and EPSC amplitudes revealed no significant difference between genotypes (p>0.5).
Slow and prolonged GABA B receptor mediated IPSPs in TCR cells play an important role in generating rebound excitation. We investigated postsynaptic GABA B responses in TCR cells by adding baclofen (50 µM) to the perfusate for 2 minutes (Fig. 3A-C) .
Membrane potential and input resistance were monitored with a K + -based recording solution. Baclofen induced a small hyperpolarization of a few mV that was not significantly different between WT (-3.1 ± 1 mV, n=8 cells), 1a -/-(-2.5 ± 1 mV, n = 6) and 1b -/-mice (-3.4 ± 2.3 mV, n = 7) (Fig. 3D ). This hyperpolarization was associated with a decrease in input resistance as assessed by small hyperpolarizing current pulses. Statistical comparison revealed that the baclofen-induced relative decrease in input resistance was similar for all genotypes (WT: 65 ± 10%, n=8 cells; 1a -/-: 77 ± 8%, n=6; 1b -/-: 71 ± 9%, n=6) (ordinary one-way ANOVA).
In summary, our electrophysiological recordings in the thalamus reveal a nonredundant functional role of GABA B(1a,2) receptors at glutamatergic terminals, while GABA B(a1,2) and GABA B(1b,2) receptors at GABAergic terminals and postsynaptic sites independently mediate full inhibition.
Discussion
Our experiments demonstrate that predominantly the GABA B(1a,2) receptor subtype controls the release of glutamate from corticothalamic fibers. This finding corroborates results from other brain regions (Shaban et al. 2006; Vigot et al. 2006) , and shows that the preferential association of GABA B(1a,2) receptors with glutamatergic terminals is a common feature. This predominance is interesting from a mechanistic point of view. The only region of sequence divergence between GABA B1a and GABA B1b subunits are two extracellular "sushi domains" that are unique to GABA B1a (Ulrich and Bettler 2007) . The sushi domains are evolutionarily conserved protein-interaction motifs. It is therefore reasonable to assume that they bind to protein(s) that are necessary for the localization of GABA B1a at glutamatergic terminals. The GABA B1a subunit is individually regulated at the transcriptional level (Steiger at al. 2004) , which, in principle, allows to dynamically adjust the level of presynaptic inhibition at glutamatergic synapses. A small but non-significant baclofeninduced inhibition of EPSC amplitudes of ~30 % was observed in 1a -/-mice, similar to previous studies (Shaban et al. 2006 , Vigot et al. 2006 ). This remaining inhibition may reflect the presence of a small amount of GABA B(1b,2) receptors at excitatory terminals.
Possibly, the significant up-regulation of GABA B1b protein in the 1a -/-mice contributes to this remaining inhibition (Vigot et al. 2006) . However, functional heteroreceptors in 1a -/-mice may also reflect that the mechanism leading to a dendritic distribution of GABA B1b is not absolute. The fact that baclofen-induced EPSC inhibition remains normal in 1b -/-mice further suggests a high receptor reserve and supports that GABA B receptor subtypes do not interact linearly with presynaptic effector systems. The physiological conditions under which presynaptic GABA B receptors at corticothalamic fiber terminals become activated are not known (Nyitrai et al. 1996) . However, it is assumed that reticular cells, which inhibit We found that GABA B(1a,2) and GABA B(1b,2) receptors inhibit GABA release onto TCR cells to a similar extent. Likewise, autoreceptor function in the amygdala and the hippocampus was found to be mediated by both receptor subtypes (Shaban et al. 2006; Vigot et al. 2006) . In contrast, the GABA B(1a,2) receptor subtype exclusively conveyed autoreceptor function in the supragranular layers of the neocortex (Perez-Garci et al.
2006
). This finding raised the possibility that different types of interneurons exclusively express one or the other subtype of GABA B receptors. However, reticular neurons are traditionally considered a homogeneous cell population (Ohara and Lieberman 1985) and local interneurons are absent in the rodent somatosensory thalamus (Barbaresi et al. 1986 ). Our findings in the thalamus therefore support that GABA B(1a,2) and GABA B(1b,2) receptors are co-expressed in individual inhibitory neurons and that individual receptor subtype are sufficient to meditate autoreceptor function to its full extent. Alternatively, TRN neurons may consist of more than a single cell type (e.g. Spreafico et al. 1991) , which could express one or the other receptor subtype at their terminals. Although the existence of GABA B autoreceptors on the terminals of TRN cells was also demonstrated in earlier electrophysiological experiments (Le Feuvre et al. 1997; Ulrich and Huguenard, 1996) , a recent morphological study failed to detect GABA B subunits at these structures (Kulik et al. 2002) . In this context it is important to note that it has been generally difficult to demonstrate the existence of autoreceptors using immunohistochemical or ultrastructural techniques (Bettler et al. 2004 ). This probably reflects that the level of GABA B autoreceptor expression is below the detection limit of immunochemical methods. It therefore appears that near GABA release sites few GABA B autoreceptors are sufficient to efficiently inhibit neurotransmitter release. It remains puzzling why electrophysiological recordings show a non-redundant functional role of GABA B(1a,2) receptors at glutamatergic terminals only. In addition to differences in expression and distribution it cannot be ruled out that the mode of presynaptic inhibition is different for GABA B receptor subtypes and that this contributes to the observed differences between glutamatergic and GABAergic terminals. In that context it was shown that GABA B receptors can inhibit the release machinery independent of their effects on Ca 2+ channels (Sakaba et al, 2003) .
GABA B(1a,2) and GABA B(1b,2) receptors activate postsynaptic K + channels in TCR neurons equally well (Fig. 3) . GABA B(1a,2) receptors therefore significantly contribute to K 
